Clofazimine-induced cutaneous hyperpigmentation as a source of stigma in the treatment of leprosy: A cross-sectional study.
Andreza Soares NogueiraMonique Allana Chagas GarciaMoises Batista da SilvaPatricia Fagundes da CostaMarco Andrey Cipriani FradeClaudio Guedes SalgadoJosafá Gonçalves BarretoPublished in: Tropical medicine & international health : TM & IH (2024)
All patients presented skin hyperpigmentation caused by clofazimine, detectable through spectrophotometry. Hyperpigmentation strongly impacted the social domain, indicating the intersectionality of disease and skin colour stigma, contributing to the social isolation of these patients. Health authorities should consider the negative impact of clofazimine on treatment adherence.
Keyphrases
- end stage renal disease
- mental health
- healthcare
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- physical activity
- social support
- patient reported outcomes
- soft tissue
- depressive symptoms
- replacement therapy
- oxidative stress
- climate change
- weight loss
- human immunodeficiency virus
- diabetic rats
- insulin resistance
- patient reported